IFRS 17's CSM: Unpacking the Two Sides of Profit Growth

Imagine your insurance company’s future profit as a locked jar of money. This jar is the Contractual Service Margin (CSM) under IFRS 17. It holds all the profit you expect to earn over the lifetime of your insurance contracts. Each reporting period, you unlock a portion of that profit and recognize it as revenue. But the total amount in the jar also changes. Understanding why it changes is one of the most powerful insights IFRS 17 offers.

The movement in the CSM is not a single story; it’s two very distinct narratives. The standard requires us to separate the changes into two main buckets: the impact of new business written during the period, and the impact of changes in estimates for the existing business.

New Business: Adding to the Jar

First, let's look at new business. When you sell a new profitable policy, you calculate the expected future profit and add it directly to the CSM jar. This is straightforward and a key indicator of your company's growth and current pricing strategy. A large increase in CSM from new business is a clear signal of a successful sales period. It tells stakeholders that you are effectively generating new, profitable contracts and growing your future earnings base. This is the growth story.

Changes in Estimates: Re-evaluating What's Inside

The second type of change is more nuanced. This happens when you re-evaluate the future for policies you've already sold. You might update your assumptions based on new experience or changing trends. For example, if you realize policyholders are living longer (for annuities) or lapsing less than you originally predicted, your future cash flows will change. These adjustments can either increase or decrease the CSM.

A positive adjustment (an increase in CSM) means your original assumptions were conservative. A negative adjustment means they were optimistic. This part of the CSM movement isn't about new sales; it's about the accuracy of your past predictions and your ability to manage your in-force portfolio. This is the actuarial accuracy and risk management story.

Why This Distinction is Crucial for Analysis

Separating these two sources of change is vital for any meaningful analysis of an insurer's performance. An investor or executive might see a headline number showing a $100 million increase in the CSM. Without the breakdown, this number is ambiguous. Was that $100 million driven by stellar sales of new policies? Or was it because the company released overly prudent assumptions from prior years?

The first scenario points to a strong, growing business. The second tells a different story—one about past conservatism and the quality of historical underwriting and actuarial assumptions. While releasing prudence is often positive, it's a one-time gain that doesn't necessarily reflect the underlying health of current operations.

By clearly disclosing the CSM movement from new business versus changes in estimates, IFRS 17 provides a transparent view into the engine room of an insurer. It allows you to distinguish between sustainable growth from new sales and the recalibration of past performance, giving you a truer picture of financial health and future profitability.